Information processing device, information processing method, and program

Abstract

To provide a display device for displaying clinical examination values, with which it is possible to efficiently grasp the information necessary for prescription audit on prescriptions prescribed for patients.SOLUTION: A display device for displaying clinical examination values comprises: grouping means for accepting medicine described in prescriptions and clinical examination values and groping the clinical examination values on the basis of a relationship between the medicine and the clinical examination values; and display means for displaying the grouped clinical examination values distinguishably on a display unit. The display device for displaying the clinical examination values displays the clinical examination values classified by grouping into groups that are mutually different in clinical examination values for each medicine.SELECTED DRAWING: Figure 3

Description

Technical Field

[0001] The present invention relates to an information processing apparatus, an information processing method, and a program.

Background Art

[0002] The development of information processing technology has also widely penetrated medical institutions such as pharmacies that dispense and provide drugs, enhancing convenience. For example, conventionally in medical institutions, computers such as rececons that assist in creating receipts (medical fee statements) have been known, enabling the creation of receipts without the need for advanced specialized knowledge or complex calculations. In recent years, systems for electronically managing patient information such as medical histories have also become widespread.

[0003] Conventionally, since the rececon and the system for managing medical histories were hard - independent computers, for example, in Patent Document 1, a pharmacy computer equipped with a rececon function and a medical history management function discloses a pharmacy computer in which both functions are effectively linked.

Prior Art Documents

Patent Documents

[0004]

Patent Document 1

Summary of the Invention

Problems to be Solved by the Invention

[0005] By the way, when dispensing drugs to patients, prescription audits are conducted to check whether there are any suspicious points in directly delivering the drugs as they are based on the items described in the prescription and patient information, medication history, etc. In such prescription audits, clinical test values that can grasp the patient's injury or illness status and the effects of the drugs being taken may be referred to. However, there are numerous clinical test values, and even if a large number of input clinical test values are displayed haphazardly, it is impossible to efficiently grasp the information regarding the target injury or illness and drugs. As a result, even if information such as clinical test values is displayed for prescription audits, it is impossible to efficiently search for the information of the necessary clinical test values, so it has become impossible to quickly conduct appropriate prescription audits.

[0006] The present invention has been made in view of such a situation, and an object thereof is to provide a display device and a program that display clinical test values that can efficiently grasp the information necessary for prescription audits for prescriptions prescribed to patients.

Means for Solving the Problem

[0007] (1) A display device for displaying clinical test values, comprising: grouping means for receiving drugs and clinical test values described in a prescription and grouping the clinical test values based on the relationship between the drugs and the clinical test values; and display means for displaying the grouped clinical test values on a display unit so as to be distinguishable for each group.

[0008] (2) The display device for displaying clinical test values according to (1), wherein the grouping may be such that one clinical test value is classified into different groups for each drug.

[0009] (3) The display device for displaying clinical test values according to (1) or (2), wherein the grouping is performed for each effect and side effect of the drug.

[0010] (4) The display device for displaying clinical test values according to (3), wherein the grouping may be such that when the value of the clinical test value is a predetermined value, it is classified into the side effect part of the drug.

[0011] (5) The display means is a display device that displays a clinical test value having the relationship with the drug and a clinical test value not having the relationship with the drug in response to receiving the selection of the drug, and displays the clinical test value according to any one of (1) to (4).

[0012] (6) The display means is a display device that displays the clinical test value while distinguishing it by the place where the clinical test value is acquired, and displays the clinical test value according to any one of (1) to (5).

[0013] (7) A grouping step of receiving the drug and the clinical test value described in the prescription and grouping the clinical test value based on the relationship between the drug and the clinical test value, and a display step of displaying the grouped clinical test value on a display unit so as to be distinguishable for each group, and causing a computer to execute them, a program.

[0014] Note that for the selection of the drug column, the prescription audit related information column, and the cross-reference column, it is only necessary to receive the selection of any one column and display the specific information. The selection may be only the drug column, only the prescription audit related information, only the cross-reference column, the selection of the drug column and the prescription audit related information column, the selection of the drug column and the prescription audit related information column, the selection of the prescription audit related information column and the cross-reference column, or the selection of the drug column, the prescription audit related information column, and the cross-reference column to display the specific information.

Effect of the Invention

[0015] According to the present invention, it is possible to efficiently grasp the information necessary for the prescription audit of the prescription prescribed to the patient.

Brief Description of the Drawings

[0016]

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

Figure 11

Figure 12

[0017] Hereinafter, with reference to the drawings, one embodiment of the present invention will be described.

[0018] [First Embodiment] [Configuration of Display System 100 for Displaying Clinical Test Values] Referring to FIG. 1, a display system 100 for displaying clinical test values of the present invention includes an administrator device 1, display devices 2a ··· 2n for displaying clinical test values used by the person in charge on the pharmacy side, and a display 3 for notifying the patient of the progress of the drug supply service.

[0019] The display devices 2a ··· 2n for displaying clinical test values are terminal devices used by the person in charge of each operation constituting the drug supply service. Here, referring to FIG. 2(1), the drug provision service is composed of a series of processes. After receiving a prescription from a patient at the counter, the drug is dispensed according to the prescription, and when it is recognized in the final inspection that the dispensing is appropriate, the drug is provided to the patient at the counter. Such a drug provision service can be composed of each operation shown in FIG. 2(2) as an example, that is, "reception", "drug history confirmation", "prescription inspection", "patient information collection", "dispensing design", "explanation regarding taking medicine", "dispensing decision", "dispensing", "final inspection", "drug delivery accounting". Some of these operations can proceed independently of each other. In this embodiment, these operations are divided among a plurality of persons in charge. For example, among the operations constituting the drug provision service, Pharmacist A is in charge of "reception", "patient information collection", "dispensing", and "drug delivery accounting", Pharmacist B is in charge of "drug history confirmation", "prescription inspection", "dispensing design", "explanation regarding taking medicine", and "dispensing decision", and Pharmacist C is in charge of "final inspection". In such an embodiment, for example, the display device 2a for displaying clinical test values is used by Pharmacist A, the display device 2b for displaying clinical test values is used by Pharmacist B, and the display device 2c for displaying clinical test values is used by Pharmacist C. Of course, the display devices 2a ··· 2n for displaying clinical test values may not only be used by one person in charge but also be shared and used by a plurality of persons in charge. Since the configurations of the display devices 2a ··· 2n for displaying clinical test values are basically the same, they may hereinafter be simply referred to as "the display device 2 for displaying clinical test values".

[0020] The administrator device 1 is a terminal device having administrator authority such as extension, change, and restriction of the functions of the display device 2 for displaying clinical test values, and is used by an administrator who manages each person in charge. It is a general-purpose personal computer including a control unit that performs various arithmetic processes and a storage unit that stores various information, and is provided with an input unit realized by a keyboard, a touch panel, etc. and a display unit by a display.

[0021] The display device 2 for displaying clinical test values is intended to comprehensively support the operations in a pharmacy and is realized by a general-purpose personal computer, similar to the administrator device 1. Such a display device 2 for displaying clinical test values has various programs installed, and the control unit operates according to these programs to exhibit functions such as a prescription input function, a medication history management function, and a task sharing function, and also to display clinical test values in "prescription review". Note that clinical test values are those referred to when grasping the state of a patient's illness or the degree of influence of a drug, and refer to values obtained by qualitatively or quantitatively measuring components, cells, etc. contained in a patient. In a pharmacy, they are referred to in "prescription review" to determine whether the effect of a drug is sufficient or whether side effects of the drug have occurred. These administrator device 1 and the display device 2 for displaying clinical test values are connected by a predetermined network line and cooperate with each other to support the business of providing drugs to patients.

[0022] The display 3 is arranged facing the patient side who visits the pharmacy and displays the progress status indicating the progress of the drug provision service for the patient. The display 3 is communicably connected to the administrator device 1 and / or the display device 2 for displaying clinical test values and displays the progress status according to instructions from the administrator device 1 and / or the display device 2 for displaying clinical test values.

[0023] [Functional Configuration of the Display Device 2 for Displaying Clinical Test Values] Subsequently, with reference to FIG. 3, the configuration of the display device 2 for displaying clinical test values will be described. The display device 2 for displaying clinical test values has, in the control unit 21, a reception means 211, an extraction means 212, a grouping means 213, and a display means 214, and has, in an area of the storage unit 22, a patient DB 221, a clinical test value DB 222, and an attached document DB 223.

[0024] The reception means 211 receives the content of a prescription slip at a specific hospital visit of a patient and the patient's clinical test values, and stores the prescription slip content and the clinical test values in the patient DB 221 in association with the patient ID. Here, the prescription details refer to information about the content described in the prescription and information generated incidental to the receipt of the prescription. For example, it includes specific patient information such as the patient's name, the prescribed medicine (prescription drug), the receipt date indicating the date when the pharmacy received the prescription, and whether the drug described in the prescription is prescribed to the patient for the first time (first administration), etc. Also, clinical test values are stored including, for example, biological tests related to the patient's condition such as blood pressure and pulse, and specimen tests of components and cells that the patient has by analyzing specimens collected from the patient such as blood glucose level, red blood cell count, urine protein, and γ-GTP. As will be described later, the prescription details and clinical test values received by the reception means 211 are used when the extraction means 212 extracts the patient's past prescription details and clinical test values, or when the grouping means 213 groups the clinical test values.

[0025] The extraction means 212 extracts from the patient DB the types and values of the patient's past prescription details and clinical test values associated with the patient ID of the patient who received the prescription. Also, based on the received prescription details, the types, and values of the clinical test values, the extraction means 212 extracts from the clinical test value DB222 the relationship between the drug included in the received prescription details and the clinical test values.

[0026] Next, referring to FIG. 4, the patient DB 221 will be described. The patient DB 221 is a DB that stores the prescription details and clinical test values received at the pharmacy, and is configured to store the prescription details and clinical test values received by the reception means 211 in association with the patient ID. The patient DB 221 has a "patient ID" in which information for identifying the patient is stored, a "patient name" in which the patient's name is stored, a "reception date" in which the date when the prescription was received is stored, a "drug" in which the prescribed drug that is the received prescription detail is stored, a "clinical test value item" in which the type of the received clinical test value is stored, and a "clinical test value" in which the value of the received clinical test value is stored. In the value of the "clinical test value", in addition to quantitative values such as specific numbers, qualitative values indicating the presence or absence of the clinical test value are stored. For example, for the clinical test value of systolic blood pressure, a quantitative value that is a specific number of 95 mgHG is stored, and for the clinical test value of urine protein, a qualitative value indicating that the clinical test value has been detected, such as present / absent, is stored. Note that the patient DB 221 may be configured to include, in addition to such information, other personal information of the patient, information on drugs, and information related to information on clinical test values.

[0027] Next, referring to FIG. 5, the clinical test value DB 222 will be described. The clinical test value DB 222 is a DB having a relational table that stores the relationship between drugs and the type and value of clinical test values, and a normal value table that stores the normal values of clinical test values. In the relational table, a "drug" that is information on drugs, a "clinical test value item" that stores the type of clinical test value, a "clinical test value" that stores the value of the clinical test value, and a "relationship" that is the relationship between the drug and the type and value of the clinical test value are stored. In the normal value table, the clinical test value and its normal value are stored. Note that the clinical test value DB 222 may be configured to include, in addition to such information, other information related to the relationship between drugs and clinical test values. The normal value table may be configured to have different normal values depending on gender, age, etc. Here, specifically, "relationship" refers to information indicating what kind of relationship the clinical test value has for the drug. For example, for a drug called antihypertensive agent A, the clinical test value of systolic blood pressure is information indicating a "drug effect" relationship. Also, for example, for a drug called antihypertensive agent A, the clinical test value of γ-GTP is information indicating a "drug side effect" relationship. Moreover, such relationships are not limited to drug effects and side effects, and there may be three or more relationships. For example, for a drug called antihypertensive agent A, for the clinical test value of pulse, a relationship such as "drug effect (off-label)" may be established. Here, off-label means using the drug for symptoms not included in the approved content of the drug. Also, "relationship" may be configured such that even for the same drug and type of clinical test value, the relationship changes depending on the value. For example, for a drug called antihypertensive agent A, the information that the clinical test value of systolic blood pressure indicates a "drug effect" relationship is stored. On the other hand, if the value of systolic blood pressure is "100 mmHg or less", the information that it indicates a "drug side effect" relationship is also stored. In this case, for antihypertensive agent A, if the systolic blood pressure exceeds 100 mmHg, the systolic blood pressure is classified only as a "drug effect", but if the systolic blood pressure is 100 mmHg or less, the systolic blood pressure is classified as both a "drug effect" and a "drug side effect".

[0028] Also, referring to FIG. 6, the package insert DB223 will be described. In the package insert DB223, the data of the package insert of the drug is stored in association with the drug for each item. The package insert is a written product information document for doctors and medical institution personnel that describes the drug name, precautions for use, item specifications, and other important matters in the drug. In the package insert DB223, in addition to the drug name, information such as efficacy and usage indicating indications and usage and dosage, precautions for use, side effects, etc. are stored corresponding to the items of the package insert. Also, although not particularly illustrated, in addition to the information described in the package insert, items outside the package insert such as long-term administration check drugs and high-risk drugs may be provided.

[0029] The grouping means 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test values extracted by the extraction means 212. Here, the reason why the grouping means 213 groups the clinical test values for each drug will be described. When dispensing drugs to a patient, in order to perform a prescription audit to confirm whether there is any suspicion in directly delivering the drug as it is based on the prescription items and patient information, medication history, etc., it is sometimes necessary to refer to the clinical test values that can grasp the patient's injury condition and the effects of the drugs being taken. However, there are many clinical test values, and even if all the clinical test values obtained during the prescription audit are displayed, they may include clinical test values that are not affected by the prescribed drug. In this way, if clinical test values that are not affected by the drug intake are displayed, there is a risk that the clinical test values to be grasped during the prescription audit cannot be grasped, or it may take time to grasp them. Also, even for clinical test values affected by drug intake, if clinical test values related to the effects of the drug and clinical test values related to the side effects of the drug are mixed, it is difficult for the pharmacist to intuitively grasp the clinical test values when performing the prescription audit. Therefore, the display device 2 that displays the clinical test values displays the clinical test values affected by the drug and groups and displays the clinical test values based on the relationship between the drug and the clinical test values for each drug.

[0030] Specifically, the process of the grouping means 213 grouping the clinical test values for each drug based on the relationship between the drug and the clinical test values will be exemplified and described. For example, in this embodiment, for the clinical test values of patient A, namely systolic blood pressure, pulse, γ-GTP, and blood glucose level, extracted by the grouping means 213, for drug A, systolic blood pressure, diastolic blood pressure, and pulse are grouped as "drug effects". Also, since patient A has a systolic blood pressure of 90 mmHg, for drug A, systolic blood pressure and γ-GTP are grouped as "drug side effects". Here, the maximum blood pressure, minimum blood pressure, and pulse were grouped as the "effects of the drug". However, since the relationship between drug A and the pulse is an "effect of the drug (outside the indication)", it may be possible to group the maximum blood pressure and minimum blood pressure as the "effects of the drug" and the pulse as a different group from the "effects of the drug" as the "effect of the drug (outside the indication)".

[0031] The display means 214 generates data for a display screen configured to group clinical test values based on the prescription form content and clinical test values received by the reception means 211, and the clinical test values and relationships extracted by the extraction means 212, so that each clinical test value can be distinguished according to the relationship between the drug and the clinical test value, and displays the data on the display unit 24. Further, the display means 214 displays the medication period of the drug based on the received prescription form content and the past prescription form content extracted by the extraction means 212. Further, in response to receiving the selection of the drug displayed from the input unit 23, the display means 214 limits the display to the clinical test values related to the drug, groups the clinical test values, and generates data for a display screen configured to distinguish each clinical test value according to the relationship between the drug and the clinical test value, and displays the data on the display unit 24.

[0032] Here, the display screen data displayed by the display means 214 on the display unit 24 will be described with reference to FIG. 7. FIG. 7 is a diagram showing that the display screen data generated by the display means 214 is displayed on the display unit 24. The displayed screen is an example of a display screen displayed when the pharmacist "Taro Higashi" selects "Drug A" when conducting a prescription review for the patient "A". The pharmacist refers to this screen to conduct a prescription review and confirm the prescription content based on the prescription form entries, patient information, medication history, and clinical test values.

[0033] The display area V1 is a screen that illustrates the medication period of the prescribed drug. In the display area V1, the date is shown on the horizontal axis, and the details of the prescription received by the reception means 211 and the drugs prescribed in the past are shown on the vertical axis. And a bar indicating the period during which the drug was prescribed is displayed in the central part. For example, as in B1, it shows that drug B was prescribed for 7 days from May 1st. Also, when the medication period of the drug in a given prescription overlaps with the medication periods of the drugs in the prescriptions before and after it, the bars are shifted up and down so that they do not overlap, and a bar indicating this is displayed below the period where the medication periods overlap. For example, as in B2, the bar indicating the 21-day supply of drug A prescribed on April 16th is shifted up, and the bar indicating the 30-day supply of drug A prescribed on May 1st is shifted down, and a bar indicating the overlap is displayed for the period from May 1st to May 6th. The drugs displayed in the display area V1 are each configured to display the clinical test values related to the selected drug in the subsequent display area V2 in response to receiving a selection.

[0034] In the display areas V2, V3, and V4, the clinical test values of the prescribed drugs are displayed in a distinguishable manner. V2, V3, and V4 in FIG. 7 show that, upon receiving the selection of drug A, the clinical test values related to drug A are displayed in a distinguishable manner for each relationship. In the display area V2, the clinical test values whose relationship with drug A is "effect of the drug" are displayed. For example, in the display area V2, the maximum blood pressure, minimum blood pressure, and pulse rate, whose relationship with drug A is "effect of the drug", are displayed as the same group. Also, in the display area V3, the clinical test values whose relationship with drug A is "side effect of the drug" are displayed. For example, the maximum blood pressure, γ-GTP, and urinary protein, whose relationship with drug A is "side effect of the drug", are displayed as the same group. Note that the maximum blood pressure displayed as a "side effect of the drug" is displayed as such because the value on May 1st was 100 or less. If there were no times when the maximum blood pressure value was 100 or less, the maximum blood pressure would not be displayed as a "side effect of the drug".

[0035] Display area V4 has received the selection of drug A and displays clinical test values that have no relationship with drug A. For example, fasting blood glucose and HbA1C, which are not affected by drug A, are displayed as the same group.

[0036] Graphs showing changes in respective clinical test values are displayed in display areas V2, V3, and V4. The horizontal axis of the graph shows the date, and the vertical axis shows the value of the clinical test value. Also, in the center of the graph, a normal value range indicating the normal value of the clinical test value is shown, and quantitative clinical test values are displayed as a line graph of the values of the clinical test values. Also, qualitative clinical test values are displayed as +- so that the presence or absence can be understood. Here, the date on the horizontal axis can be changed by pressing the scale enlargement or reduction button, and it can be changed from daily to weekly, monthly, etc. Also, for the clinical test value on the vertical axis, the normal value of the clinical test value to be displayed is extracted from clinical test value DB222, and the scale unit of the vertical axis is adjusted and displayed so that the normal value ranges of the respective clinical test values are the same. For example, the maximum blood pressure, minimum blood pressure, and pulse displayed in V3 are 100 - 129, 60 - 79, and 50 - 90 respectively, and the values of the scale (lower limit of the scale, interval of the scale, and upper limit of the scale) on the vertical axis are adjusted to be different for each clinical test value so that the normal value ranges of the respective clinical test values are the normal value range display in the graph.

[0037] In this way, the necessity of the vertical axis so that the normal value range displays are the same for each is explained with reference to the simplified FIG. 8. In V5 of FIG. 8, the maximum blood pressure and minimum blood pressure are displayed, but the scales of the respective clinical test values are displayed to be the same, and the normal value range displays are different. However, when displayed in this way, there is a problem that it is difficult to intuitively understand which line graph of the value of the clinical test value the normal value range corresponds to, and this problem becomes more difficult to intuitively understand as the number of types of clinical test values increases. Therefore, in the display device 2 that displays clinical test values, the scale values are adjusted so that they fall within the same range for different types of clinical test values with different normal value ranges. Note that the display in FIG. 7 and the display in FIG. 8 may be configured to accept a user's selection and switch between each other.

[0038] [Operation of the Display Device 2 for Displaying Clinical Test Values] Subsequently, with reference to FIG. 8, the operation of the display device 2 for displaying clinical test values will be described. First, the reception means 211 receives the prescription details or / and the clinical test values (step S1). After that, the reception means 211 associates the received prescription details or / and the clinical test values with the patient ID and stores them in the patient DB 221 (step S2). After that, the extraction means 212 extracts information regarding past prescription details, clinical test values, and the relationship between drugs and clinical test values necessary for generating display image data (step S3). After that, the grouping means 213 groups the clinical test values for each drug based on the relationship between the drugs and the clinical test values extracted by the extraction means 212 (step S4). After that, the display means 214 groups the clinical test values based on the prescription details and clinical test values received by the reception means 211 and the clinical test values and relationships extracted by the extraction means 212, and generates data for a display screen configured such that each clinical test value can be distinguished according to the relationship between the drug and the clinical test value (step S5). After that, the display means 214 outputs the generated display screen data to the display unit 24 (step S6).

[0039] After that, the reception means 211 receives the selection of a drug (step S7). After that, the display means 214 generates data for a display screen limited to the clinical test values related to the selected drug in response to the reception means 211 receiving the selection of the drug (step S8). After that, the display means 214 outputs the generated display screen data to the display unit 24 (step S9).

[0040] As described above, in the present embodiment, clinical test values not affected by the prescribed drug are not displayed, and only clinical test values related to the prescribed drug are displayed. Therefore, the pharmacist can appropriately grasp the efficacy and side effects of the prescribed drug and efficiently grasp the information necessary for prescription monitoring of the prescription sheet prescribed to the patient.

[0041] Also, in the present embodiment, clinical test values not affected by the prescribed drug are not displayed, and only clinical test values related to the prescribed drug are displayed. Therefore, the pharmacist can appropriately grasp the efficacy and side effects of the prescribed drug and efficiently grasp the information necessary for prescription monitoring of the prescription sheet prescribed to the patient.

[0042] Also, in the present embodiment, among the prescribed drugs, clinical test values not affected by the drug selected by the pharmacist are not displayed, and only clinical test values related to the drug selected by the pharmacist are displayed. Therefore, the pharmacist can appropriately grasp which of the prescribed drugs affect the clinical test values and cause efficacy and side effects, and can efficiently grasp the information necessary for prescription monitoring of the prescription sheet prescribed to the patient.

[0043] Also, in the present embodiment, clinical test values not affected by the prescribed drug are not displayed, and only clinical test values related to the prescribed drug are displayed, and among them, the relationships are displayed differently depending on the values of the clinical test values. Therefore, the pharmacist can intuitively grasp the meaning of the displayed clinical test values among the prescribed drugs and efficiently grasp the information necessary for prescription monitoring of the prescription sheet prescribed to the patient.

[0044] [Second Embodiment] In the first embodiment, the display device 2 includes, in the control unit 21, a reception unit 211, an extraction unit 212, a grouping unit 213, and a display unit 214, and in an area of the storage unit 22, it has a patient DB 221, a clinical test value DB 222, and an attached document DB 223. On the other hand, in the present embodiment, as shown in FIG. 10, the control unit 21 includes a reception unit 211a, an extraction unit 212, a grouping unit 213, a display unit 214a, and a display switching reception unit 215, and in an area of the storage unit 22, there are a patient DB 221a, a clinical test value DB 222, and an attached document DB 223. Hereinafter, the functional configuration of the present embodiment will be described. Note that the description of functions similar to those of the first embodiment will be omitted.

[0045] The reception unit 211a receives the content of a prescription slip at a specific hospital visit of a patient, the clinical test values of the patient, and the acquisition location of the clinical test values, and stores the prescription slip content, the clinical test values, and the acquisition location of the clinical test values in the patient DB 221a in association with the patient ID. The reception unit 211a can distinguish the acquisition location of the clinical test values, such as whether the entity that acquired the clinical test values is a medical institution or a patient, etc., and if the entity that acquired the clinical test values is a medical institution, what is the type of the medical institution.

[0046] Also, referring to FIG. 11, the patient DB 221a will be described. The patient DB 221a is a DB that stores the content of a prescription slip and clinical test values received at a pharmacy, and is configured to store the content of the prescription slip and the clinical test values received by the reception unit 211 in association with the patient ID. The patient DB 221a has a "patient ID" in which information for identifying the patient is stored, a "patient name" in which the patient's name is stored, a "reception date" in which the date when the prescription slip was received is stored, a "drug" in which the prescribed drug that is the content of the received prescription slip is stored, a "clinical test value item" in which the type of the received clinical test values is stored, a "clinical test value" in which the value of the received clinical test values is stored, and in addition, a "acquisition location of clinical tests".

[0047] Returning to FIG. 10, the display switching reception unit 215 receives the display method of the clinical test values, and displays the clinical test values corresponding to the received display method on the display unit 24. Specifically, the display switching reception means 215 receives the display method of clinical test values. The display method of clinical test values is a display method for whether to distinguish and display according to the acquisition location of clinical test values. When the display method of clinical test values is to distinguish and display, the method of such distinction is selected. The display method of clinical test values receives, for example, any one of the selections of "not distinguish", "distinguish and change display according to location", "distinguish and display only at medical institutions", and "distinguish and display only at home".

[0048] The display means 214a groups the clinical test values based on the prescription details and clinical test values received by the reception means 211 and the clinical test values and relationships extracted by the extraction means 212, and generates data for a display screen configured such that each clinical test value can be distinguished according to the relationship between the drug and the clinical test value, and displays it on the display unit 24. The display means 214a displays the clinical test values according to the display method received by the display switching reception means 215.

[0049] Here, the display screen data displayed by the display means 214a on the display unit 24 will be described with reference to FIG. 12. FIG. 12 is a diagram showing that the display screen data generated by the display means 214a is displayed on the display unit 24. Note that points common to the first embodiment will be briefly described.

[0050] FIG. 12(1) is the display data generated by the display means 214a when the display switching reception means 215 receives "not distinguish". In the display area V2a, since "not distinguish" is selected, the clinical test value of systolic blood pressure is displayed as the graph L1 without distinguishing the acquisition location. FIG. 12(2) is the display data generated by the display means 214a when the display switching reception means 215 receives "distinguish and change display according to location". In the display area V2a, since "change display according to the location for differentiation" is selected, the clinical test value of the systolic blood pressure where the obtained location is α Hospital is displayed as the line graph L2, and the clinical test value of the systolic blood pressure where the obtained location is home is displayed as the line graph L3. Figure 12(3) is the display data generated by the display means 214a when the display switching reception means 215 receives "display only for medical institutions for differentiation". In the display area V2a, since "display only for medical institutions for differentiation" is selected, the clinical test value of the systolic blood pressure where the obtained location is α Hospital is displayed as the line graph L4. Note that the clinical test value of the systolic blood pressure where the obtained location is home is excluded from the line graph L4 and only the mark is displayed.

[0051] In this way, by displaying the clinical test values while differentiating the locations where the clinical test values are obtained, it is possible to appropriately grasp the effectiveness and side effects of the prescribed drugs. For example, in the case of systolic blood pressure, when measured by medical staff, the patient may be nervous and a blood pressure higher than the original blood pressure may be displayed. Therefore, the pharmacist can grasp the original systolic blood pressure by differentiating and displaying the location where the systolic blood pressure is obtained.

[0052] As described above, in this embodiment, since the clinical test values can be displayed while differentiating the locations where the clinical test values are obtained, the pharmacist can appropriately grasp the effectiveness and side effects of the prescribed drugs and efficiently grasp the information necessary for the prescription audit of the prescription sheet prescribed to the patient.

[0053] Note that the present invention is not limited to the above-described embodiment, and modifications, improvements, etc. within the scope that can achieve the object of the present invention are included in the present invention.

[0054] Furthermore, the invention of the present application can be applied to a terminal device having the functional configuration shown in FIG. 3. At this time, having the functional configuration shown in FIG. 3 means that in addition to installing software for realizing the functional configuration in the terminal device, it also includes a state in which the terminal device can use the software installed in a predetermined server via a network. That is, the invention of the present application can also be applied to a so-called ASP service that provides business applications to customers through the Internet.

[0055] Also, in the present embodiment, the clinical test values displayed by selecting a drug are displayed based on a group based on the relationship with the selected drug. However, before accepting the selection, the clinical test values may be displayed based on the relationship with all drugs. Further, by selecting an item of the clinical test value or a line graph on the graph, a display may be made to clarify the drugs having a relationship with the selected clinical test value. Here, the display for clarifying the drug means that, for example, only the drugs having a relationship may be displayed on the display unit, or a display that is emphasized such that the display color of the drugs having a relationship is different from that of other drugs may be made.

[0056] Also, in the present embodiment, clinical test values having no relationship with the drug are displayed in the display area V4. However, the present invention is not limited to this. For example, without providing the display area V4, clinical test values having no relationship may not be displayed.

[0057] Also, in the present invention, the clinical test values received by the reception means 211 are not limited to whether the acquired medical institution is any one of them. For example, they may be clinical test values acquired at a pharmacy where the display device 2 is installed, or clinical test values acquired at a medical institution other than the pharmacy where the display device 2 is installed. The clinical test values acquired at other medical institutions received by the reception means 211 are not limited to the clinical test values input by the person in charge by asking the patient. They may also be received via a network line from other medical institutions.

[0058] The above series of processes can be executed by hardware or by software. In other words, the functional configuration of FIG. 3 is merely illustrative and not particularly limited. That is, it suffices that a computer is provided with a function capable of executing the above series of processes as a whole, and the functional blocks used to realize this function are not particularly limited to the example of FIG. 3. Also, one functional block may be configured by hardware alone, by software alone, or by a combination thereof.

[0059] When the series of processes are to be executed by software, the program constituting the software is installed in a computer or the like from a network or a recording medium. The computer may be a computer incorporated in dedicated hardware. Also, the computer may be a computer capable of executing various functions by installing various programs, for example, a general-purpose personal computer.

Explanation of Reference Numerals

[0060] 1 Administrator device 2 Display device for displaying clinical test values 3 Display 21 Control unit 22 Storage unit 23 Input unit 24 Display unit 211 Reception means 212 Extraction means 213 Grouping means 214 Display means 221 Patient DB 222 Clinical test value DB 223 Attached document DB

Claims

1. a prescription database storing information regarding patient prescriptions; a patient test value database storing information regarding clinical test values ​​of patients; A relationship extraction means for extracting a relationship between a drug included in the prescription of the patient and the clinical test value based on relationship information defining the relationship between the drug and the clinical test value; a grouping means for grouping the clinical test values ​​of the patients for each of the extracted relationships; an output means for outputting the clinical test values ​​of the grouped patients in association with the relationships together with the medicines included in the prescription; An information processing device comprising:

2. The information processing apparatus according to claim 1 , wherein the relationships include relationships representing effects of the medicines and relationships representing precautions for prescriptions.

3. 3. The information processing device according to claim 1, wherein the output means displays the clinical test values ​​of the patient for each of the relationships with the selected drug in response to receiving a selection of any of the displayed multiple drugs.

4. The information processing apparatus according to claim 1 , wherein in the grouping, one of the clinical test values ​​can be grouped into different relationships for each of the drugs.

5. An information processing method executed by an information processing device capable of referring to a prescription database that stores information on patient prescriptions and a patient test value database that stores information on patient clinical test values, comprising: A relationship extraction step of extracting a relationship between a drug included in the prescription of the patient and the clinical test value based on relationship information defining the relationship between the drug and the clinical test value; A grouping step of grouping the clinical test values ​​of the patients for each of the extracted relationships; an output step of associating the grouped clinical test values ​​of the patients with the relationships and outputting the results together with the medicines included in the prescription; 13. An information processing method comprising:

6. A computer that can access a prescription database that stores information about patient prescriptions and a patient test value database that stores information about patient clinical test values, A relationship extraction function that extracts a relationship between a drug included in the prescription of the patient and the clinical test value based on relationship information that defines the relationship between the drug and the clinical test value; a grouping function for grouping the clinical test values ​​of the patients for each of the extracted relationships; an output function of associating the clinical test values ​​of the grouped patients with the relationships and outputting the results together with the medicines included in the prescription; A program for realizing the above.

Images